Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Horizon Kinetics Medical ETF (MEDX:NASDAQ), powered by AI.
Horizon Kinetics Medical ETF is currently trading at $34.19. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Horizon Kinetics Medical ETF on Alpha Lenz.
Horizon Kinetics Medical ETF's P/E ratio is 20.7.
“Horizon Kinetics Medical ETF trades at a P/E of 20.7 (fair value) with solid ROE of 12.3%.”
Ask for details →Horizon Kinetics Medical ETF is an exchange-traded fund designed to provide investors exposure to the healthcare and medical sector. The primary function of this ETF is to offer a diversified portfolio of investments across companies involved in various aspects of healthcare, including biotechnology, pharmaceuticals, medical devices, and healthcare services. Notably, the fund focuses on innovative and dynamic companies that are at the forefront of medical research, development, and manufacturing globally. This sector is crucial due to its fundamental role in addressing public health challenges and advancing medical technology and treatments. The ETF operates under the oversight of Horizon Kinetics, a firm known for its analytical and research-driven investment approach. By investing in this ETF, market participants can potentially gain broad exposure to healthcare advancements and trends without having to pick individual stocks, thereby participating in the growth and significance of the medical industry within the global economy.
“Horizon Kinetics Medical ETF trades at a P/E of 20.7 (fair value) with solid ROE of 12.3%.”
Ask for details →Horizon Kinetics Medical ETF (ticker: MEDX) is a company listed on NASDAQ in the Unknown sector (Unknown). Market cap is $20.0B.
The current price is $34.19 with a P/E ratio of 20.67x and P/B of 2.35x.
ROE is 12.31% and operating margin is 9.99%. Annual revenue is $17.6B.